Close Menu

Shimadzu

The Regents of the University of California have been awarded

Shimadzu said last week that it has registered several of its HPLC and LC-MS instruments as Class I medical devices with the US Food and Drug Administration, allowing them to be used in clinical settings.

NEW YORK (GenomeWeb News) – Shimadzu said today that it has registered several of its HPLC and LC-MS instruments as Class I medical devices with the US Food and Drug Administration, allowing them to be used in clinical settings.

NEW YORK (GenomeWeb News) – Shimadzu today announced the creation of a wholly owned subsidiary in Uruguay to bolster its Central and South American business.

Shimadzu said this week that its US manufacturing subsidiary Shimadzu USA Manufacturing has obtained ISO 13485 certification for the manufacture of its liquid chromatography and mass spectrometry systems.

NEW YORK (GenomeWeb News) – Shimadzu USA Manufacturing said today it has obtained ISO 13485 certification for the manufacture of high performance liquid chromatographs and liquid chromatograph-mass spectrometry systems.

New Products: Shimadzu, Agilent

Premium

Shimadzu this week announced the launch of its LabSolutions CS chromatography data system for controlling Agilent's 1100, 1200, 1260, and 1290 series HPLC systems.

Shimadzu has launched its new LCMS-8050 triple quadrupole.

Shimadzu has released its Perfinity NoRA trypsin columns for use with the Perfinity Workstation and Perfinity Integrated Digestion platform.

New Products: ASMS 2013 Focus

Premium

A number of vendors introduced new proteomics products at the American Society for Mass Spectrometry meeting in Minneapolis this week. The following is a roundup of new offerings introduced at the conference.

Pages

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.